Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets

v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 2,647 $ 2,505
Accounts receivable 5,925 5,649
Other current assets 1,391 1,746
Total current assets 9,963 9,900
Property and equipment, net 1,315 1,423
Operating lease right of use assets 1,110 1,217
Deferred tax asset 20,977 21,254
Other long-term assets 44 44
Total assets 33,409 33,838
Current liabilities:    
Accounts payable 805 983
Accrued salary and bonus 714 1,886
Other accrued expenses 1,783 1,574
Current liabilities of discontinued operations 660 660
Total current liabilities 3,962 5,103
Operating lease liabilities, net of current portion 635 752
Other long-term liabilities 5,730 5,620
Total liabilities 10,327 11,475
Commitments and contingencies (Note 7)
Stockholders’ equity:    
Redeemable preferred stock, $.01 par value; 5,000,000 shares authorized, 0 and 47,000 shares Series C issued and outstanding, respectively
Common stock, $.01 par value; 100,000,000 shares authorized; 27,844,994 and 4,569,333 shares issued, respectively; 27,700,904 and 4,428,539 shares outstanding, respectively 640 407
Additional paid-in capital 234,604 234,833
Accumulated deficit (210,084) (210,805)
Treasury stock, at cost (144,090 and 140,794 shares, respectively) (2,078) (2,072)
Total stockholders’ equity 23,082 22,363
Total liabilities and stockholders’ equity $ 33,409 $ 33,838